Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism BRD2 inhibitors(Bromodomain-containing protein 2 inhibitors), BRD4 inhibitors(Bromodomain-containing protein 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Inflammation | Preclinical | Germany | 30 Dec 2025 | |
| Inflammation | Preclinical | United Kingdom | 30 Dec 2025 | |
| Neoplasms | Preclinical | Germany | 30 Dec 2025 | |
| Neoplasms | Preclinical | United Kingdom | 30 Dec 2025 |





